Healthy potentially undervalued

Results

91

6 new

Companies which are potentially undervalued and in an acceptable financial position.

91 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
	VSTM	US$4.10	11.7%	-27.3%	US$360.3m	US$16.00	7.3	51.3%	n/a
	CRMD	US$8.74	2.3%	-39.1%	US$685.7m	US$15.20	3.8	-4.5%	n/a
	ARQT	US$24.38	13.2%	81.9%	US$3.0b	US$34.63	7.3	48.5%	n/a
	REGN	US$612.14	0.1%	17.1%	US$62.3b	US$833.31	14.1	11.7%	0.6%
	ELAN	US$24.17	2.1%	72.8%	US$12.1b	US$29.79	2.5	55.8%	n/a
	SUPN	US$44.41	-0.2%	36.8%	US$2.6b	US$62.83	3.3	50.5%	n/a
	PBH	US$47.82	0.2%	-42.8%	US$2.3b	US$66.80	11.9	12.4%	n/a
	ARDX	US$5.69	2.7%	55.5%	US$1.4b	US$16.33	3.3	56.3%	n/a
	COLL	US$34.64	4.1%	16.6%	US$1.1b	US$54.33	15.0	41.9%	n/a
	TARS	US$61.95	3.9%	50.0%	US$2.7b	US$94.11	5.0	53.9%	n/a
	DERM	US$6.34	5.7%	-5.9%	US$174.6m	US$13.50	2.7	44.0%	n/a
	FENC	US$9.00	1.1%	10.2%	US$312.6m	US$15.67	6.1	49.3%	n/a
	XGN	US$4.67	11.2%	-37.2%	US$112.8m	US$8.67	1.6	27.6%	n/a
	PRGO	US$10.99	-5.3%	-58.8%	US$1.5b	US$16.50	0.4	87.9%	10.6%
	AMPH	US$20.09	3.6%	-22.7%	US$885.8m	US$22.83	11.2	-0.7%	n/a
	QGEN	US$37.06	2.3%	-25.8%	US$7.7b	US$43.82	19.1	12.4%	6.5%
	ADMA	US$8.21	1.9%	-59.8%	US$1.9b	US$17.60	11.5	20.5%	n/a
	ZVRA	US$12.65	4.6%	38.6%	US$747.8m	US$27.89	6.4	18.6%	n/a
	EXEL	US$53.13	2.7%	27.3%	US$13.4b	US$49.00	16.0	12.1%	n/a
	MDGL	US$480.77	2.9%	68.7%	US$11.1b	US$678.71	9.8	59.2%	n/a
	VTRS	US$16.48	3.5%	83.3%	US$19.2b	US$17.81	1.3	50.6%	2.9%
	VNDA	US$5.87	-1.2%	28.2%	US$353.0m	US$14.13	1.6	62.4%	n/a
	TARA	US$3.90	-3.5%	23.0%	US$219.2m	US$26.57	1.2	53.8%	n/a
	ACAD	US$21.09	-2.8%	-4.7%	US$3.6b	US$31.65	9.6	12.1%	n/a

Page 1 of 3